Akcelis was contacted by a pharma company to raise awareness for a rare disease. The rare disease has a worldwide incidence of 4,6 to 7,4 per 100.000 inhabitants.
Akcelis implemented a stepwise approach:
A project in mind? Let us explore the solutions for your project.
Akcelis has developed the patient management platform C-Lys to facilitate it services. This platform is patient friendly, multilingual, GAMP5 validated and GDPR compliant.